INV-102 Ophthalmic Solution

INV-102 · Invirsa, Inc.

Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for INV-102 Ophthalmic Solution, covering 2025-07-02 to 2026-04-27. Get the full timeline:

Most recent: Clinical Trial Results: Study of INV-102 Ophthalmic Solution in Adults With Moderate Symptomatic Dry Eye Disease [Phase 1, Phase 2]